TF
BMY icon

Talbot Financial’s Bristol-Myers Squibb BMY Stock Holding History

Talbot Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-99,996
Closed -$5.66M – 64
2024
Q4 		$5.66M Buy
99,996
+5,813
+6% +$325K 0.67% 45
2024
Q3 		$4.87M Buy
94,183
+5,950
+7% +$279K 0.59% 46
2024
Q2 		$3.66M Buy
88,233
+9,964
+13% +$446K 0.47% 44
2024
Q1 		$4.24M Buy
78,269
+5,345
+7% +$272K 0.57% 45
2023
Q4 		$3.74M Sell
72,924
-5,524
-7% -$290K 0.56% 44
2023
Q3 		$4.55M Buy
78,448
+3,763
+5% +$231K 0.79% 44
2023
Q2 		$4.78M Buy
74,685
+8,078
+12% +$542K 0.81% 44
2023
Q1 		$4.62M Buy
66,607
+4,308
+7% +$304K 0.86% 43
2022
Q4 		$4.48M Buy
+62,299
New +$4.7M 0.92% 40

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Talbot Financial's BMY Position: Q1 2025 in Review

Talbot Financial sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 99,996 shares — an estimated $5.66M sold.

Talbot Financial first reported a position in BMY in Q4 2022 and held it in 9 quarters. The position peaked at $5.66M in Q4 2024. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Talbot Financial reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Talbot Financial sold 99,996 Bristol-Myers Squibb shares in Q1 2025, an estimated $5.66M.
  • Talbot Financial first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 9 quarters.
  • Talbot Financial's Bristol-Myers Squibb position peaked at $5.66M in Q4 2024.
  • 2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Talbot Financial's 13F filing for Q1 2025, filed 9 Apr 2025.